Revenue in the third quarter was $40.8 million and grew 23% over prior year and was impacted by prioritized travel and vacations for our patient demographic, which led to lower than anticipated demand for our lapoplasty procedure during the quarter.

Nov 9, 2023 / CEO / receipt, needs a key / John Treece, CEO | earnings call 2023-11-09 | transcript bc3fd02a-7b91-47aa-8ce0-90c637b31a51 | chars 5477-5726 | segment 5